Multimodal therapy for painful bladder syndrome/interstitial cystitis

Area of Science:

• Urology
• Gastroenterology
• Immunology

Background:

• Interstitial cystitis (PBS/IC) presents significant challenges in diagnosis and treatment.
• Dysfunctional urothelium, mast cell activation, and neural upregulation are key pathological components.

Purpose of the Study:

• To outline effective diagnostic and treatment strategies for PBS/IC.
• To highlight the benefits of a multimodal approach for managing PBS/IC.

Main Methods:

• Utilizing validated screening and diagnostic tools like the Pelvic Understanding of Functional મુત્રાશય (PUF) and Pelvic Symptom Tally (PST).
• Implementing multimodal treatment including oral pentosan polysulfate (PPS), antihistamines (e.g., hydroxyzine), and tricyclic antidepressants (TCAs) (e.g., amitriptyline).
• Incorporating adjunctive therapies such as behavioral interventions and intravesical instillation.

Main Results:

• Accurate diagnosis is facilitated by available screening tools.
• Multimodal oral therapy (PPS, hydroxyzine, amitriptyline) demonstrates significant benefit.
• Intravesical therapies, including lidocaine, heparin, or PPS, offer immediate symptom relief.

Conclusions:

• PBS/IC is a manageable condition with timely diagnosis and prompt treatment.
• A comprehensive approach addressing urothelial dysfunction, mast cell activation, and neural upregulation is crucial.
• Patient education and support are vital for successful long-term management.